AstraZeneca, Merck & Co and Alexion all scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.

Moderna, a US-based messenger RNA (mRNA) therapeutics developer backed by pharmaceutical companies AstraZeneca, Merck & Co and Alexion, raised approximately $604m in its initial public offering on Friday.

The IPO, the largest ever for a biotech company, consisted of almost 26.3 million shares issued on the Nasdaq Global Select Market priced at $23.00 each, up from 21.7 million shares when it set a $22 to $24 range late last month. The offering valued it at approximately $7.52bn.

Moderna…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn